Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 8Cholangiocarcinoma 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Skin Neoplasms 4Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lung Neoplasms 3Liver Neoplasms 3Leukoplakia, Oral 3Colorectal Neoplasms 3Bile Duct Neoplasms 3Warts 2Tongue Neoplasms 2Prostatic Neoplasms 2Pleural Diseases 2Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Esophageal Neoplasms 2Carcinoma, Squamous Cell 2Bowen's Disease 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Diseases 1

Interventions

pembrolizumab 188Cisplatin 47Paclitaxel 45Carboplatin 44lenvatinib 31Docetaxel 23Pemetrexed 21Fluorouracil 20Capecitabine 17Gemcitabine 15Oxaliplatin 14Saline Solution 13Albumin-Bound Paclitaxel 11130-nm albumin-bound paclitaxel 10epacadostat 9Leucovorin 9Cetuximab 9olaparib 7Irinotecan 7Bevacizumab 7Etoposide 6enzalutamide 5belzutifan 5Dexamethasone 5durvalumab 4Surgical Procedures, Operative 4Radiotherapy 4Nivolumab 4trifluridine tipiracil drug combination 3spartalizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Parkinson Disease 4, Autosomal Dominant Lewy Body × Photochemotherapy × Clear all
NCT05386056 2022-11-28

Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

Peking University

Phase 2 Unknown
54 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡